Latest Brisbane News

Vicinity Centres delivered a resilient 3Q FY26 with high occupancy, strong retail sales growth, and a $654 million capital raise through long-dated debt issuances, reaffirming its FY26 earnings guidance at the top end.

Emyria Limited reported $1.2 million in revenue for the March quarter, driven by insurer-funded clinics and strong clinical outcomes in PTSD treatment. The company is advancing its national clinic rollout, including new sites in Victoria and New South Wales, while launching a global partnership program targeting international drug sponsors.

GR Production Services secures a five-year $57 million operations and maintenance contract at the Sturt Plateau Compression Facility in the Northern Territory's Beetaloo Basin, with potential extension for three more years.

Transurban showcased the West Gate Tunnel’s technology and benefits as April traffic data revealed growth in Melbourne and Brisbane but a dip in Sydney. Commercial vehicle volumes surged, while North American toll prices climbed sharply in the March quarter.

Nuix has appointed John Ruthven as its permanent CEO and Managing Director, ending a global search and signalling leadership continuity following his interim role since November 2025.

Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.

NeuroScientific Biopharmaceuticals reported positive clinical responses in its StemSmart™ Special Access Program for fistulising Crohn’s disease and has initiated manufacturing technology transfer to support Phase 2 trials planned for late 2026.

Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.

Emyria Limited is extending its Empax mental health clinic network into New South Wales through a new partnership with Matilda Nepean Private Hospital, increasing treatment capacity and national reach ahead of a planned Q3 2026 launch.

Emyria reported $1.2 million revenue for Q1 2026 driven by insurer-funded clinics and expanded its Empax network across multiple states. It launched a Global Partnership Program targeting international drug sponsors, leveraging its clinical infrastructure amid growing global interest in psychedelic therapies.

HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.

Venari Minerals has delivered a maiden JORC Inferred Mineral Resource Estimate for its Red Mountain Lithium Project in Nevada, revealing 3.03 million tonnes of contained Lithium Carbonate Equivalent. The company also reported improved beneficiation results and completed a share buyback to streamline its register.